Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group-Reference-Cited by-同舟云学术

Flow cytometric analysis of de novo acute lymphoblastic leukemia in childhood: report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Published:2011-07-30 Issue:2 Volume:94 Page:185-192
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Iwamoto Shotaro,Deguchi Takao,Ohta Hideaki,Kiyokawa Nobutaka,Tsurusawa Masahito,Yamada Tomomi,Takase Kozo,Fujimoto Junichiro,Hanada Ryoji,Hori Hiroki,Horibe Keizo,Komada Yoshihiro

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-011-0900-1.pdf

Reference32 articles.

1. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood. 1993;82:343–62.

2. Borowitz MJ, Shuster J, Carroll AJ, Nash M, Look AT, Camitta B, et al. Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study. Blood. 1997;89:3960–6.

3. Möricke A, Zimmermann M, Reiter A, Henze G, Schrauder A, Gadner H, et al. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24:265–84.

4. Escherich G, Horstmann MA, Zimmermann M, Janka-Schaub GE, COALL study group. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82, 85, 89, 92 and 97. Leukemia. 2010;24:298–308.

5. Kamps WA, e Bruin KM, Veerman AJ, Fiocco M, Bierings M, Pieters R. Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia. 2010;24:309–19.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunophenotypic and clinicohematological characteristics of T-ALL cases detected over a three-year period in a tertiary institution;Indian Journal of Pathology and Oncology;2024-09-15

2. Treatment of relapsed acute lymphoblastic leukemia in children: an observational study of the Japan Children’s Cancer Group;International Journal of Hematology;2024-08-27

3. Inotuzumab ozogamicin as a bridging therapy to allogeneic hematopoietic stem cell transplantation in children with refractory/relapsed B-cell acute lymphoblastic leukemia;Pediatric Hematology/Oncology and Immunopathology;2024-05-14

4. Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead;Blood Advances;2023-07-12

5. Dual targeting of CD19 and CD22 against B-ALL using a novel high-sensitivity aCD22 CAR;Molecular Therapy;2023-07